Is vedicitomab suitable for long-term maintenance treatment?

Vedicitumumab can be used as long-term maintenance therapy in HER2-positive advanced tumors, with the goals of maintaining tumor stability, delaying progression, and improving quality of life. Clinical studies have shown that patients who continue treatment can benefit in terms of disease control rate and progression-free survival. However, long-term medication requires regular review of cardiac function, liver function and blood indicators to prevent cumulative toxicity, and the dose should be adjusted based on efficacy and tolerability. Individualized treatment and dynamic assessment are core principles of long-term maintenance strategies to ensure that patients receive maximum benefit without increasing uncontrollable risks.